Russell Investments Group
AVEO

Russell Investments Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Russell Investments Group’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,638
Closed -$16K – 3273
2020
Q1 		$16K Buy
+4,638
New +$23K ﹤0.01% 2967

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group's AVEO Position: Q2 2020 in Review

Russell Investments Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2020, closing a stake of 4,638 shares — an estimated $16K sold.

Russell Investments Group first reported a position in AVEO in Q1 2020 and held it in 1 quarter. The position peaked at $16K in Q1 2020. 65 funds tracked by Wall St. Rank hold AVEO as of Q2 2020.

  • Russell Investments Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Russell Investments Group sold 4,638 AVEO Pharmaceuticals, Inc. shares in Q2 2020, an estimated $16K.
  • Russell Investments Group first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2020 and held it in 1 quarter.
  • Russell Investments Group's AVEO Pharmaceuticals, Inc. position peaked at $16K in Q1 2020.
  • 65 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2020.

Based on Russell Investments Group's 13F filing for Q2 2020, filed 5 Aug 2020.